Actos, TVM and Zohydro litigation discussed by Andy Birchfield and Leigh O’Dell on Ringler Radio

Ringler Radio, a popular radio program conducted by the nation’s largest structured settlement company, Ringler Associates, introduced Beasley Allen attorneys Andy Birchfield and Leigh O’Dell to discuss their progress on litigation involving Actos, Transvaginal Mesh and Zohydro. Actos is a prescription medication for type-2 diabetes or adult-onset diabetes. One of many drugs used to treat diabetes, Actos distinguishes itself by being from a class of drugs known as TZDs. TZDs have been the culprit of many problems in the past, such as with the diabetes drug Resulin, which was pulled off the market after causing liver failure and many deaths in its users. Actos has been linked to the development of bladder cancer. Transvaginal mesh is separated into two types of products: one is used to treat pelvic organ prolapse (POP) and the other for stress urinary incontinence. Due to the use of this dangerous mesh, millions of women are forced to live in constant internal pain from the erosion of the mesh within them. Birchfield and O’Dell also talked about emerging concerns about the painkiller Zohydro. Manufactured by Zogenix Inc., Zohydro is a painkiller with between five and 10 times more of the semi-synthetic opioid hydrocodone than common painkillers including Vicodin and Lortab. However, the Zohydro lacks any abuse deterrents that have been built into newer painkillers.


We're here to help!

We live by our creed of "helping those who need it most" and have helped thousands of clients get the justice they desperately needed and deserved. If you feel you have a case or just have questions please contact us for a free consultation. There is no risk and no fees unless we win for you.

Fields marked    may be required for submission.
  1. I'm an attorney

FDA reclassifies transvaginal mesh as high-risk device

As of Jan. 4, 2016, transvaginal mesh or TVM, has been reclassified by the U.S. Food and Drug...

$2.4 Billion Actos Bladder Cancer Settlement Explained

Beasley Allen principal Frank Woodson discusses the recent $2.4 billion Actos settlement on Ringler...

Jury awards $100 million to woman injured by...

A Delaware jury ordered Boston Scientific Corp. to pay a Newark woman a record $100 million in damages...
Takeda settles Actos bladder cancer lawsuits for $2.4 billion

$2.4 billion settlement agreement reached in Actos...

Takeda Pharmaceutical Co. has agreed to a $2.4 billion settlement to resolve bladder cancer claims tied...
Federal jury orders drugmakers to pay $9 billion for actos cancer risk

Actos verdict illustrates companies that co-promote...

A federal judge’s decision not to overturn a jury’s $9 billion verdict against Takeda Pharmaceutical...

Transvaginal mesh linked to serious, life-altering...

Many people use medical devices every day. For the most part these devices improve the life of those...

I never dreamed how much this would mean to me

I received another check today, much to my surprise. Thank you, thank you, thank you! I never dreamed how much this would mean to me in my golden years, as I have had hearing problems for years and needed to update my hearing aids, but with a limited income, found that was impossible. I now have the best hearing aids that I have ever had, thanks to you fighting so hard on my behalf.

—Gladys